Highlights
About
Targeted Technology for Cancer Therapy and Diagnostics
CTX Platforms is a biotechnology company rapidly advancing towards a disruptive targeted technology application for imaging and treatment of brain cancers and other non-CNS tumors.
The company is developing a theranostic system, potentially capable of imaging living brain tumors and treating brain cancer in children and adults with non-invasive magnetic fields heating technology. This novel technology is based on the sophisticated delivery of magnetic nanoparticles directly to their location in the brain and the induction of focal heat to destroy the cancer cells. Together with existing immunotherapy, this adjuvant treatment can potentially offer new hope for people with GBM.
CTX develops its proprietary particles under license from cutting edge technology and academic centers.
Identity
| Name | CTX Platforms |
|---|---|
| Slug | ctx-platforms |
| Type / kind | startup |
| Crunchbase ID | ctx-platforms |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJm5s8ILDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Jul 2023 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | South District |
| HQ city | Be'er Sheva |
| HQ address | Be'er Sheva, Israel |
Web & social
| https://www.linkedin.com/company/29749349 |
Classifications
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}